🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SENEA and executed a BUY strategy, securing a +19.05% net profit.

UPGRADE TO SEE LIVE SIGNALS

$VERU

Veru Inc

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP-2.93%
MAX GAP RECORD-13.50%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.5%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL